Effects Of Scapulothoracic Intervention With Or Without Neural Mobilization In Patients With Cervico-Brachialgia
21. juli 2026 oppdatert av: Riphah International University
Effects Of Scapulothoracic Intervention With Or Without Neural Mobilization On Pain, Function, And Neural Mechano-Sensitivity In Patients With Cervico Brachialgia
Cervicobrachialgia is a common musculoskeletal condition characterized by neck pain radiating into the upper limb due to neural and musculoskeletal dysfunctions.
It is often associated with pain, functional disability, and increased neural mechanosensitivity, significantly affecting daily activities and quality of life.
Various physiotherapy interventions have been used to manage this condition, including neural mobilization and scapulothoracic rehabilitation.
However, evidence regarding the combined effectiveness of these interventions remains limited.
Studieoversikt
Status
Har ikke rekruttert ennå
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The aim of the study is to determine the effects of scapulothoracic intervention with or without neural mobilization on pain, function, and neural mechanosensitivity in patients with cervicobrachialgia.
Methods: A randomized controlled trial will be conducted on 40 patients diagnosed with cervicobrachialgia. Participants will be randomly allocated into two groups, with 20 participants in each group. Group A received scapulothoracic rehabilitation combined with neural mobilization (ST+NM), while Group B received neural mobilization alone (NM). Treatment will be administered according to the study protocol over the intervention period. Outcome measures includes the Numeric Pain Rating Scale (NPRS) for pain intensity, Neck Pain Questionnaire (NPQ) for neck-related disability, PainDETECT Questionnaire (PDQ) for neuropathic pain symptoms, and Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire for upper limb function. Assessments were performed before and after the intervention. Data will be analyzed using paired sample t-tests, independent sample t-tests, Mann-Whitney U tests, and Wilcoxon Signed Rank tests with a significance level of p<0.05.
Studietype
Intervensjonell
Registrering (Antatt)
44
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Sumrod Akram
- Telefonnummer: 03324806143
- E-post: samrood.akram@riphah.edu.pk
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
Tar imot friske frivillige
Nei
Beskrivelse
Inclusion Criteria:
- Cervicobrachial pain
- Females and males
- Aged 30-50 years
- Able to communicate and follow the instructions
- Able to perform cervical exercises according to cervicogenic pain
Exclusion Criteria:
- Negative neurodynamic test
- Neck and upper extremity surgery
- Vertebral instability
- Vertebral spine infection
- Neurological disease of genetic, infection, or neuroplastic origin
- Inflammatory or systemic disease
- VBI symptoms
- Rheumatoid arthritis
- Subjects with presence of any fractures.
- Heart/diabetic patient
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Scapulothoracic intervention with Neural Mobilization
Group A received Scapulothoracic intervention with Neural Mobilization
|
Neural Mobilization: Pain-free tension
|
|
Aktiv komparator: Neural Mobilization
Group B received Neural Mobilization alone.
|
Neural Mobilization: Pain-free tension
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Visual Analogue Scale (VAS)
Tidsramme: upto 6 weeks
|
The VAS is a common, subjective measurement tool that is used to measure the level of pain severity using an 11-point range with zero (no pain) and ten (heaviest pain imaginable).
Patients use a subjective scale to rate their pain verbally and the following scales apply to 1-3 mild, 4-6 moderate, and 7-10 severe pain.
|
upto 6 weeks
|
|
Northwick Park Neck Pain Questionnaire (NPQ)
Tidsramme: upto 6 weeks
|
The NPQ is a 9- questionnaire assessing neck pain disability with each question put on a scale of 0 to 4(code converted to percentage).
It examines nocturnal sleep, activities during the day, and social goals.
With cervicobrachialgia, it is used to measure functional restrictiveness such as neck/arm pain.
Scores: 0-20 percent (light), 21-40 percent (moderate), >40 percent (severe).
|
upto 6 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
PainDETECT questionnaire (PD-Q)
Tidsramme: upto 6 weeks
|
It is a 9-item instrument that has 7 scored items 0-5, and 2 items of the pain pattern characteristics of neuropathic pain in cervicobrachialgia.
score 0-38: <13 (not likely neuropathic), 13-18 (indeterminate), >=19 (probable neuropathic).
It assesses the quality of pain (burning, tingling etc.), radiation patterns.
|
upto 6 weeks
|
|
Disability of Arm, Shoulder and Hand (DASH)
Tidsramme: upto 6 weeks
|
The DASH assesses upper limb disability and is a 30 item questionnaire scaled 1-5.
The total point (0-100) is counted: [(the sum of the responses/n) -1] x 25.
The higher the score and the more they are disabled.
The course is minimal clinically significant difference, 10 points.
In case of cervicobrachialgia, it examines the impairment of arm functioning.
|
upto 6 weeks
|
|
FABF Questionnaire (FABQ)
Tidsramme: upto 6 weeks
|
FABQ contains 16 items consisting of two subscales namely, physical activity (4 items, 0-24) and work (7 items, 0-42).
The more the score, the higher fear-avoidance.
In cervicobrachialgia, scores above 14 (work) or 12 (physical activity), predict an unsatisfactory recovery.
|
upto 6 weeks
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Hovedetterforsker: Ramish Safraz, Riphah International University
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Generelle publikasjoner
- Wagner FM. [Somatic dysfunction of the cervical spine and its complex clinical picture : The fundamentals of diagnostics of cervicobrachialgia and cervicocephalic syndrome through manual medicine]. Orthopade. 2022 Apr;51(4):263-273. doi: 10.1007/s00132-022-04228-7. Epub 2022 Mar 3. German.
- Sanchez AC, Requena JBS, Pantaleaon LAL, Esqueda ATI, Raidi VMV, Gallardo IR, et al. # 36401 Post-traumatic compressive C6 cervicobrachialgia, not all that glitters is gold. BMJ Publishing Group Ltd; 2023.
- Kerimova EK, Isaikin AI, Romanova AS, Bashlachev MG, Mouki K. Cervicalgia and cervicobrachialgia in periarticular cyst at the cervical level. Case report. Consilium Medicum. 2025;27(02):94-8.
- Thomson S, Ainsworth G, Selvanathan S, Brown S, Croft J, Kelly R, Mujica-Mota R, Rousseau N, Higham R, Stocken D. Clinical and cost-effectiveness of PCF versus ACD in the treatment of cervical brachialgia (FORVAD trial). Br J Neurosurg. 2024 Feb;38(1):141-148. doi: 10.1080/02688697.2023.2267119. Epub 2024 Jan 27.
- Fujastawan IGV. Management of Physiotherapy in Case of Brachialgia Due to Cervical Spondyloarthrosis. Science Midwifery. 2022;10(2):755-8.
- Rani A, Chopra J, Singh RR, Bajpai PK. Prevalence of various anomalies of costal element at cervico-thoracic junction in and around lucknow region of uttarpradesh: A radiological study. Biomed Res. 2021;32(1):7-14.
- AHMED AA, SHABAN M. Conservative Treatment of Cervical Discs without Myelopathy: A Three Years Follow-up. The Medical Journal of Cairo University. 2023;91(03):403-7.
- Thomson S, Ainsworth G, Selvanathan S, Kelly R, Collier H, Mujica-Mota R, Talbot R, Brown ST, Croft J, Rousseau N, Higham R, Al-Tamimi Y, Buxton N, Carleton-Bland N, Gledhill M, Halstead V, Hutchinson P, Meacock J, Mukerji N, Pal D, Vargas-Palacios A, Prasad A, Wilby M, Stocken D. Posterior cervical foraminotomy versus anterior cervical discectomy for Cervical Brachialgia: the FORVAD RCT. Health Technol Assess. 2023 Oct;27(21):1-228. doi: 10.3310/OTOH7720.
- Korman DV, Yushmanov IG. The influence of osteopathic correction to the level of stress in patients with cervicobrachialgia. Российский остеопатический. 2020:56.
- Ilić J, Kostić A, Ilić M, Nikolov V, Stojanović N, Todorović S. Cervicobrachial syndrome: Prevalence and clinical correlation with coronavirus 2019 disease among hospitalized patients. Acta Medica Medianae. 2024;63(3).
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Antatt)
1. juli 2026
Primær fullføring (Antatt)
30. november 2026
Studiet fullført (Antatt)
30. desember 2026
Datoer for studieregistrering
Først innsendt
21. juli 2026
Først innsendt som oppfylte QC-kriteriene
21. juli 2026
Først lagt ut (Faktiske)
24. juli 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
24. juli 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
21. juli 2026
Sist bekreftet
1. juli 2026
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- REC/RCR & AHS/25/0141
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .